LIST OF TABLES AND FIGURES TABLE 1 PROJECTED REAL GDP GROWTH (ANNUAL PERCENTAGE CHANGE) OF KEY COUNTRIES TABLE 2 GLOBAL COPPER PEPTIDE GHK-CU MARKET, BY PRODUCT TYPE (USD MILLION) TABLE 3 GLOBAL COPPER PEPTIDE GHK-CU MARKET, BY APPLICATION (USD MILLION) TABLE 4 GLOBAL COPPER PEPTIDE GHK-CU MARKET, BY FORM (USD MILLION) TABLE 5 GLOBAL COPPER PEPTIDE GHK-CU MARKET, BY DISTRIBUTION CHANNEL (USD MILLION) TABLE 6 GLOBAL COPPER PEPTIDE GHK-CU MARKET, BY END-USER (USD MILLION) TABLE 7 GLOBAL COPPER PEPTIDE GHK-CU MARKET, BY GEOGRAPHY (USD MILLION) TABLE 8 NORTH AMERICA COPPER PEPTIDE GHK-CU MARKET, BY COUNTRY (USD MILLION) TABLE 9 NORTH AMERICA COPPER PEPTIDE GHK-CU MARKET, BY PRODUCT TYPE (USD MILLION) TABLE 10 NORTH AMERICA COPPER PEPTIDE GHK-CU MARKET, BY APPLICATION (USD MILLION) TABLE 11 NORTH AMERICA COPPER PEPTIDE GHK-CU MARKET, BY FORM (USD MILLION) TABLE 12 NORTH AMERICA COPPER PEPTIDE GHK-CU MARKET, BY DISTRIBUTION CHANNEL (USD MILLION) TABLE 13 NORTH AMERICA COPPER PEPTIDE GHK-CU MARKET, BY END-USER (USD MILLION) TABLE 14 U.S

AOD-9604 was created to be: Safe Non-habit forming Non-stimulating Suitable for long-term metabolic support Cycling contradicts its original design
Healthcare providers may recommend MIC B12 injections 1-3 times per week, with the exact frequency determined by individual health needs and goals [1]
Therefore, the level of evidence is considered preliminary
Improper storage weakens preservative action within opened vials
Avoid rubbing the injection site and let warm medication reach room temperature before use